Scion Life Sciences β Full Portfolio
12 tracked investments Β· listed companies and verified rows first
Stoke Therapeutics develops RNA-based antisense oligonucleotides to treat severe genetic diseases by restoring protein expression through its TANGO platform, with a lead program in late-stage clinical development for Dravet syndrome and additional programs targeting other genetic disorders of the central nervous system and eye.
BiotechBedford, US
Adrian Krainer(Executive Officer, Director, Promoter)Isabel Aznarez(Executive Officer, Director, Promoter)inHuw Nash(Executive Officer)inIan F. Smith(Chief Executive Officer and Director)Jason Hoitt(Chief Patient Officer)inThomas E. Leggett(Chief Financial Officer)
Co-investors5AM VenturesRTW Investments L.P.
Akero develops engineered protein therapies for metabolic diseases, particularly MASH (metabolic dysfunction-associated steatohepatitis) and other conditions with high unmet medical need.
BiotechHealthtechMedical Devices
Co-investorsAtlas VentureForesite CapitalFrazier Life SciencesThe Innovation SpacevenBio PartnersVersant Ventures
Ascidian Therapeutics is a biotechnology company developing RNA-based therapeutics, with a clinical focus that includes ophthalmology and inherited retinal diseases.
AI & Machine LearningBiotechHealthtech
Co-investorsATP
Centessa is a biopharmaceutical company developing an Orexin Receptor 2 Agonist program aimed at treating sleep-wake, neurological, neurodegenerative, and neuropsychiatric disorders.
BiotechHealthtech
Co-investorsAdvent Life SciencesEcoR1 CapitalForesite CapitalMedicxiOberland CapitalVida Ventures+1 more
Marengo Therapeutics is a clinical-stage biotech company developing TCR-targeting antibodies that activate specific T cell subsets by targeting Variable Ξ² (VΞ²) chain variants of the T cell receptor.
BiotechHealthtech
Petrichor provides software infrastructure for agricultural supply chains, helping merchants, traders, and processors manage supply chain decisions, financial performance, and sustainability goals.
Advanced ManufacturingAgTechData & InfrastructureEnterprise SoftwareLogistics & Supply ChainSaaSChicago, US
Co-investorsIllinois Ventures
Petrichor Capital Partners is a venture capital and private equity firm that invests in life sciences and biotech companies, with operations including a dedicated operating partner network and advisory board of scientific and medical experts.
BiotechHealthtechMedical Devices
Tadd Wessel(Founder and Managing Partner)in
RayzeBio develops radiopharmaceutical therapies for cancer treatment.
BiotechHealthtechMedical DevicesSan Diego, US
Ken Song(Executive Officer, Director)inBen Hickey(President)inAbhi Bhat, PhD(Senior Vice President, Research & Development)Deborah Charych(Executive Officer)Yi Larson(Director)
BoardAaron Royston(Director)in
Co-investorsSamsara BioCapitalSofinnova VenturesTCG CrossovervenBio PartnersVersant VenturesVivo Capital+1 more
Other
Tracked investments with no reachable website or further public details β typically companies that wound down, renamed, or were absorbed.
Chinook TherapeuticsCorvidia TherapeuticsSyntimmuneTourmaline Bio
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.